These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 22555103)
1. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer. Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103 [TBL] [Abstract][Full Text] [Related]
2. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159 [TBL] [Abstract][Full Text] [Related]
3. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells. Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219 [TBL] [Abstract][Full Text] [Related]
5. Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer. You A; Fokas E; Wang LF; He H; Kleb B; Niederacher D; Engenhart-Cabillic R; An HX J Cancer Res Clin Oncol; 2011 Apr; 137(4):621-7. PubMed ID: 20532910 [TBL] [Abstract][Full Text] [Related]
6. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells. Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144 [TBL] [Abstract][Full Text] [Related]
7. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways. Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110 [TBL] [Abstract][Full Text] [Related]
8. lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer. Yao J; Li G; Liu M; Yang S; Su H; Ye C Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970696 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859 [TBL] [Abstract][Full Text] [Related]
10. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway. Chen H; Wang Y; Xue F Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway. Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066 [TBL] [Abstract][Full Text] [Related]
12. Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro. Gu YM; Ma YH; Zhao WG; Chen J World J Gastroenterol; 2011 Sep; 17(33):3810-7. PubMed ID: 21987623 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Yue W; Sun Q; Dacic S; Landreneau RJ; Siegfried JM; Yu J; Zhang L Carcinogenesis; 2008 Jan; 29(1):84-92. PubMed ID: 18048388 [TBL] [Abstract][Full Text] [Related]
14. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell. Guo Q; Qin W J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974 [TBL] [Abstract][Full Text] [Related]
15. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina. Nakamura RE; Hunter DD; Yi H; Brunken WJ; Hackam AS BMC Cell Biol; 2007 Dec; 8():52. PubMed ID: 18093317 [TBL] [Abstract][Full Text] [Related]
16. Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3. Chen X; Ouyang L; Ke N; Pi L; Zhou X Drug Dev Res; 2024 Aug; 85(5):e22222. PubMed ID: 39003564 [TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204 [TBL] [Abstract][Full Text] [Related]
19. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Lee EJ; Jo M; Rho SB; Park K; Yoo YN; Park J; Chae M; Zhang W; Lee JH Int J Cancer; 2009 Jan; 124(2):287-97. PubMed ID: 19003969 [TBL] [Abstract][Full Text] [Related]
20. Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform. Forsdahl S; Kiselev Y; Hogseth R; Mjelle JE; Mikkola I PLoS One; 2014; 9(7):e102559. PubMed ID: 25029272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]